X

Health Care

Earnings Summary: Organon reports financial results for Q1 2024

Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and adjusted earnings for the first quarter of 2024.…

Cigna Group (CI) reports double-digit revenue growth for Q1; guides FY24

The Cigna Group (NYSE: CI), a healthcare company focused on medical insurance and related services, Thursday reported a sharp increase in…

Infographic: A snapshot of Moderna’s (MRNA) Q1 2024 earnings results

Moderna, Inc. (NASDAQ: MRNA) reported a net loss for the first quarter of 2024 when the biotechnology company's revenues declined…

Key takeaways from Pfizer’s (PFE) Q1 2024 earnings report

Shares of Pfizer Inc. (NYSE: PFE) gained over 5% on Wednesday following the company’s announcement of its first quarter 2024…

CVS Health Q1 adj. earnings drop despite revenue growth; guides FY24

Healthcare conglomerate CVS Health Corporation (NYSE: CVS) announced first-quarter 2024 results, reporting higher revenues and a decrease in adjusted earnings.…

Pfizer (PFE) Q1 2024 Earnings: Key financials and quarterly highlights

Pfizer Inc. (NYSE: PFE) reported first quarter 2024 earnings results today. Revenues decreased 20% year-over-year to $14.8 billion. Reported net…

Key highlights from Eli Lilly’s (LLY) Q1 2024 earnings results

Eli Lilly and Company (NYSE: LLY) reported first quarter 2024 earnings results today. Worldwide revenue was $8.77 billion, up 26%…

Highlights of AbbVie’s Q1 2024 financial results

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and…

Key highlights from Bristol Myers Squibb’s (BMY) Q1 2024 earnings results

Bristol Myers Squibb (NYSE: BMY) reported first quarter 2024 earnings results today. Total revenues increased 5% year-over-year to $11.9 billion.…

MRK Earnings: Merck Q1 2024 profit jumps on 9% revenue growth

Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the first quarter of…

BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite…

Earnings: Trxade Health (MEDS) reports lower revenues for fiscal 2023

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decline in revenues for fiscal 2023. The…

ISRG Earnings: Intuitive Surgical reports higher Q1 revenue and profit

Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) announced operating results for the first quarter of 2024, reporting higher revenues…

Key takeaways from Johnson & Johnson’s (JNJ) Q1 2024 earnings report

Over the years, Johnson & Johnson (NYSE: JNJ) has constantly ramped up its portfolio and pipeline. After spinning off the…

Key highlights from Abbott Laboratories (ABT) Q1 2024 earnings results

Abbott Laboratories (NYSE: ABT) reported its first quarter 2024 earnings results today. Total sales increased 2.2% year-over-year to $10 billion. Organic…

Infographic: How UnitedHealth Group (UNH) performed in Q1 2024

UnitedHealth Group (NYSE: UNH) reported its first quarter 2024 earnings results today. Revenues increased 9% year-over-year to $99.8 billion. Net…

JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q1 2024 financial results

Johnson & Johnson (NYSE: JNJ) reported first quarter 2024 earnings results today. Reported sales increased 2.3% year-over-year to $21.4 billion.…

Earnings Preview: UnitedHealth (UNH) looks poised to deliver another strong quarter

After delivering a solid performance last year, UnitedHealth Group (NYSE: UNH) will be reporting first-quarter financial data next week. The…

PACS Group gears up for $400 million IPO. Here’s all you need to know

After a slow start to the year, the IPO market is witnessing a rush of tech and healthcare companies seeking…

ANGO Earnings: Highlights of AngioDynamics’ Q3 2024 results

AngioDynamics Inc. (NASDAQ: ANGO) has reported a wider net loss for the third quarter of 2024 when the medical device…

Femasys is committed to providing women with revolutionary healthcare products: CEO

Femasys Inc. (NASDAQ: FEMY) is a healthcare company that develops women's reproductive health solutions using state-of-the-art technology. The company’s portfolio…